Literature DB >> 3093222

Emergence of beta-lactamase producing anaerobic bacteria in the tonsils during penicillin treatment.

K Tunér, C E Nord.   

Abstract

The emergence of beta-lactamase producing bacteria in the microflora in the oropharyngeal cavity was studied in ten healthy volunteers treated with 1 g phenoxymethylpenicillin b.i.d. for ten days. Beta-lactamase activity in saliva was also investigated. A significant increase in the number of beta-lactamase producing strains of Bacteroides species and Fusobacterium nucleatum was observed. One beta-lactamase producing Staphylococcus aureus strain was recovered in one of the volunteers before the penicillin administration started and three Staphylococcus aureus strains produced beta-lactamase after ten days of antibiotic treatment. Beta-lactamase-production in Haemophilus influenzae, Haemophilus parainfluenzae or Branhamella catarrhalis was not observed before, during or after the antibiotic treatment. Beta-lactamase activity was noted in the broth cultures from one volunteer colonized with a beta-lactamase producing Escherichia coli strain. Beta-lactamase activity in saliva was observed in all volunteers, the activity increasing significantly in parallel to the increase of beta-lactamase producing bacterial strains. Beta-lactamase activity in saliva was completely inhibited in vitro by clavulanic acid and p-chloromercurbenzoate and about 70-80 per cent of the activity was inhibited by cefoxitin. The increase of beta-lactamase producing bacteria in the oropharynx as a consequence of penicillin treatment raises doubt as to whether penicillin is the drug of choice in the treatment of tonsillitis caused by group A streptococci when previous treatment has failed.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3093222     DOI: 10.1007/bf02075694

Source DB:  PubMed          Journal:  Eur J Clin Microbiol        ISSN: 0722-2211            Impact factor:   3.267


  26 in total

1.  The initial kinetics of enzyme induction.

Authors:  A B PARDEE; L S PRESTIDGE
Journal:  Biochim Biophys Acta       Date:  1961-04-29

Review 2.  The beta-lactamases of gram-negative bacteria and their role in resistance to beta-lactam antibiotics.

Authors:  R B Sykes; M Matthew
Journal:  J Antimicrob Chemother       Date:  1976-06       Impact factor: 5.790

3.  beta-Lactamase-producing Branhamella catarrhalis causing otitis media in children.

Authors:  A L Kovatch; E R Wald; R H Michaels
Journal:  J Pediatr       Date:  1983-02       Impact factor: 4.406

4.  Emergence of beta-lactamase-producing aerobic and anaerobic bacteria in the oropharynx of children following penicillin chemotherapy.

Authors:  I Brook; A E Gober
Journal:  Clin Pediatr (Phila)       Date:  1984-06       Impact factor: 1.168

5.  The beta-lactamases of Bacteroides species.

Authors:  R Timewell; E Taylor; I Phillips
Journal:  J Antimicrob Chemother       Date:  1981-02       Impact factor: 5.790

6.  Isolation of beta-lactamase-producing Bacteroides strains associated with clinical failures with penicillin treatment of human orofacial infections.

Authors:  A Heimdahl; L von Konow; C E Nord
Journal:  Arch Oral Biol       Date:  1980       Impact factor: 2.633

7.  Transfer of multiple antibiotic resistance between subspecies of Bacteroides fragilis.

Authors:  G Privitera; A Dublanchet; M Sebald
Journal:  J Infect Dis       Date:  1979-01       Impact factor: 5.226

8.  Betalactamase-producing microorganisms in recurrent tonsillitis.

Authors:  K Tunér; C E Nord
Journal:  Scand J Infect Dis Suppl       Date:  1983

9.  Plasmid-mediated, transferable resistance to clindamycin and erythromycin in Bacteroides fragilis.

Authors:  F P Tally; D R Snydman; S L Gorbach; M H Malamy
Journal:  J Infect Dis       Date:  1979-01       Impact factor: 5.226

10.  Impact of phenoxymethylpenicillin and clindamycin on microflora in recurrent tonsillitis.

Authors:  K Tunér; C E Nord
Journal:  Ann Otol Rhinol Laryngol       Date:  1985 May-Jun       Impact factor: 1.547

View more
  13 in total

1.  Genetic and biochemical characterization of FUS-1 (OXA-85), a narrow-spectrum class D beta-lactamase from Fusobacterium nucleatum subsp. polymorphum.

Authors:  Christine Voha; Jean-Denis Docquier; Gian Maria Rossolini; Thierry Fosse
Journal:  Antimicrob Agents Chemother       Date:  2006-08       Impact factor: 5.191

Review 2.  Optimum treatment of streptococcal pharyngitis.

Authors:  F Scaglione; G Demartini; M M Arcidiacono; J P Pintucci
Journal:  Drugs       Date:  1997-01       Impact factor: 9.546

3.  A penicillinase-producing Fusobacterium nucleatum strain isolated from blood culture.

Authors:  G Grollier; F Guilhot; Y de Rautlin de la Roy; E Benz-Lemoine
Journal:  Eur J Clin Microbiol       Date:  1987-12       Impact factor: 3.267

4.  Tonsil surface and core cultures in recurrent tonsillitis: prevalence of anaerobes and beta-lactamase producing organisms.

Authors:  I J Mitchelmore; P G Reilly; A J Hay; S Tabaqchali
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-07       Impact factor: 3.267

Review 5.  Microbiology of chronic rhinosinusitis.

Authors:  I Brook
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-04-16       Impact factor: 3.267

6.  β-Lactamase-Producing Bacteria in Upper Respiratory Tract Infections.

Authors:  Itzhak Brook
Journal:  Curr Infect Dis Rep       Date:  2010-03       Impact factor: 3.725

7.  Activities and sources of beta-lactamase in sputum from patients with bronchiectasis.

Authors:  P Dragicevic; S L Hill; D Burnett; D Merrikin; R A Stockley
Journal:  J Clin Microbiol       Date:  1989-05       Impact factor: 5.948

8.  Effect of beta-lactamase inhibitors on the activities of various beta-lactam agents against anaerobic bacteria.

Authors:  H M Wexler; E Molitoris; S M Finegold
Journal:  Antimicrob Agents Chemother       Date:  1991-06       Impact factor: 5.191

9.  Impact of cefpodoxime proxetil and amoxicillin on the normal oral and intestinal microflora.

Authors:  B Brismar; C Edlund; C E Nord
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-09       Impact factor: 3.267

Review 10.  The role of beta-lactamase-producing-bacteria in mixed infections.

Authors:  Itzhak Brook
Journal:  BMC Infect Dis       Date:  2009-12-14       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.